Institut Català de la Salut
[González-Suárez S] Department of Surgery, Universitat Autònoma de Barcelona, Unitat Docent Vall d’Hebron, Barcelona, Spain. Servei d’Anestesiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Malalties Cardiovasculars, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Camacho Oviedo J, Pérez Lafuente M, González Junyent C, Barnés Navarro D] Servei de Radiodiagnòstic, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Suriñach Caralt JM] Department of Medicine, Universitat Autònoma de Barcelona, Unitat Docent Vall d’Hebron, Barcelona, Spain. Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Grao Roca M, Dammala Liyanage IM] Servei d’Anestesiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Mena Muñoz E] Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Martínez-Martínez M, Ruíz-Rodríguez JC] Unitat de Cures Intensives, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Shock, Disfunció Orgànica i Ressuscitació, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-06-05T11:22:53Z
2025-06-05T11:22:53Z
2025-04
Hemodynamic instability; Pulmonary embolism; Pulmonary mechanical thrombectomy
Inestabilitat hemodinàmica; Embòlia pulmonar; Trombectomia mecànica pulmonar
Inestabilidad hemodinámica; Embolia pulmonar; Trombectomía mecánica pulmonar
Background/Objectives: The incidence, timing, and predictors of hemodynamic and respiratory deterioration in patients with high-risk or intermediate-high-risk pulmonary embolism (PE) undergoing pulmonary mechanical thrombectomy (PMT) remain poorly understood. This hemodynamic and respiratory instability can lead to modifications in the anesthetic management. This study investigates these key factors and quantifies the 30-day mortality following thrombectomy. Methods: A retrospective study was conducted on 98 patients aged ≥18 years who underwent PMT. Patients were categorized based on the occurrence of cardiac arrest (CA). Results: Of the 98 patients, 34 had high-risk PE, 62 intermediate/high-risk, and 2 low risk. There were 27 cases of CA, 17 pre- and 10 intra-PMT. An SBP < 90 mmHg increases the risk of CA by 33 (p < 0.001); men have an 8-fold higher risk than women (p = 0.004); SpO2 <90% by 6 (p = 0.012); and pre-existing respiratory conditions increase the risk by 4 (p = 0.047)). N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels were 8206 ± 11660.86 and 2388.50 ± 5683.71 pg/mL (p = 0.035) in patients with and without CA, respectively. During PMT, 14% of patients required increased vasoactive drug use, and 38.77% were intubated, including 12 who required ECMO support. Sedation was administered in 64.3% of patients, while general anesthesia was used in 38.8%, with a preemptive indication in 23.5%. The survival rate of patients without CA before and/or during PMT was 96%. Conclusions: While PMT was successfully performed in all patients, hemodynamic and respiratory instability remained a significant concern. More than 10% of patients experienced severe hemodynamic instability, primarily during thrombus extraction, requiring conversion from sedation to general anesthesia. Male sex, pre-existing respiratory disease, SpO2 < 90%, and SBP < 90 mmHg were associated with an increased risk of CA. Additionally, elevated NT-proBNP levels were linked to a higher incidence of CA.
Article
Published version
English
Pressió sanguínia; Embòlia pulmonar - Tractament; Vasos sanguinis - Cirurgia; DISEASES::Cardiovascular Diseases::Vascular Diseases::Embolism and Thrombosis::Embolism::Pulmonary Embolism; Other subheadings::Other subheadings::/therapy; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Surgical Procedures, Operative::Cardiovascular Surgical Procedures::Vascular Surgical Procedures::Thrombectomy; Other subheadings::Other subheadings::Other subheadings::/adverse effects; PHENOMENA AND PROCESSES::Circulatory and Respiratory Physiological Phenomena::Cardiovascular Physiological Phenomena::Hemodynamics::Blood Pressure::Arterial Pressure; ENFERMEDADES::enfermedades cardiovasculares::enfermedades vasculares::embolia y trombosis::embolia::embolia pulmonar; Otros calificadores::Otros calificadores::/terapia; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::intervenciones quirúrgicas::procedimientos quirúrgicos cardiovasculares::procedimientos quirúrgicos vasculares::trombectomía; Otros calificadores::Otros calificadores::Otros calificadores::/efectos adversos; FENÓMENOS Y PROCESOS::fenómenos fisiológicos respiratorios y circulatorios::fenómenos fisiológicos cardiovasculares::hemodinámica::presión sanguínea::presión arterial
MDPI
Journal of Clinical Medicine;14(8)
https://doi.org/10.3390/jcm14082704
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - VHIR [1655]